All Stories

  1. Sex-specific effects of peptidyl arginine deiminase 4 deficiency in the cafeteria diet-induced obesity-associated metabolic complications

    Article • Frontiers in Endocrinology, January 2026, Frontiers

    Dr Katarina Sebekova

  2. Cafeteria and Fast-Food Diets Induce Neuroinflammation, Social Deficits, but a Different Cardiometabolic Phenotype

    Article • Nutrients, November 2025, MDPI AG

    Dr Katarina Sebekova

  3. Association of plasma levels of protein-bound advanced glycation end-products and their soluble receptors with bone mineral status in young girls with the restrictive type of anorexia nervosa

    Article • Archives of Osteoporosis, August 2025, Springer Science + Business Media

    Dr Katarina Sebekova

  4. Myeloperoxidase, extracellular DNA and neutrophil extracellular trap formation in the animal models of metabolic dysfunction-associated steatotic liver disease

    Article • World Journal of Gastroenterology, July 2025, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Katarina Sebekova

  5. Association of acrylamide dietary intake with glycation and oxidative status biomarkers and intakes of advanced glycation end-products or alpha-dicarbonyls

    Article • Scientific Reports, April 2025, Springer Science + Business Media

    Dr Katarina Sebekova

  6. Pathophysiological Role of Neutrophil Extracellular Traps in Diet-Induced Obesity and Metabolic Syndrome in Animal Models

    Article • Nutrients, January 2025, MDPI AG

    Dr Katarina Sebekova

  7. Mitochondrial DNA variability and Covid-19 in the Slovak population

    Article • Mitochondrion, March 2024, Elsevier

    Dr Katarina Sebekova

  8. Association of Leukocyte, Erythrocyte, and Platelet Counts with Metabolic Syndrome and Its Components in Young Individuals without Overt Signs of Inflammation: A Cross-Sectional Study

    Article • Children, January 2024, MDPI AG

    Dr Katarina Sebekova

  9. Metabolic Effects of Anti-TNF-α Treatment in Rheumatoid Arthritis

    Article • Diseases, November 2023, MDPI AG

    Dr Katarina Sebekova

  10. In vivo Volumetric, DTI and 1H MRS Rat Brain Protocol for Monitoring Early Neurodegeneration and Efficacy of the Used Therapy

    Article • Measurement Science Review, October 2023, De Gruyter

    Dr Katarina Sebekova

  11. Association of Atherogenic Index of Plasma with Cardiometabolic Risk Factors and Markers in Lean 14-to-20-Year-Old Individuals: A Cross-Sectional Study

    Article • Children, June 2023, MDPI AG

    Dr Katarina Sebekova

  12. Association of Inflammatory and Oxidative Status Markers with Metabolic Syndrome and Its Components in 40-To-45-Year-Old Females: A Cross-Sectional Study

    Article • Antioxidants, June 2023, MDPI AG

    Dr Katarina Sebekova

  13. Severe gestational diabetes mellitus in lean dams is associated with low IL-1α levels and affects the growth of the juvenile mouse offspring

    Article • Scientific Reports, January 2023, Springer Science + Business Media

    Dr Katarina Sebekova

  14. Association of α-Dicarbonyls and Advanced Glycation End Products with Insulin Resistance in Non-Diabetic Young Subjects: A Case-Control Study

    Article • Nutrients, November 2022, MDPI AG

    Dr Katarina Sebekova

  15. The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study

    Article • International Journal of Environmental Research and Public Health, October 2022, MDPI AG

    Dr Katarina Sebekova

  16. Extracellular DNA concentrations in various aetiologies of acute kidney injury

    Article • Scientific Reports, October 2022, Springer Science + Business Media

    Dr Katarina Sebekova

  17. The Bright Side of Skin Autofluorescence Determination in Children and Adolescents with Newly Diagnosed Type 1 Diabetes Mellitus: A Potential Predictor of Remission?

    Article • International Journal of Environmental Research and Public Health, September 2022, MDPI AG

    Dr Katarina Sebekova

  18. Lean insulin-resistant young adults display increased cardiometabolic risk: A retrospective cross-sectional study

    Article • Diabetes Research and Clinical Practice, March 2022, Elsevier

    Dr Katarina Sebekova

  19. Long-Term Consumption of a Sugar-Sweetened Soft Drink in Combination with a Western-Type Diet Is Associated with Morphological and Molecular Changes of Taste Markers Independent of Body Weight Development in Mice

    Article • Nutrients, January 2022, MDPI AG

    Dr Katarina Sebekova

  20. The Effect of Long-Term Hypogonadism on Body Composition and Morphometry of Aged Male Wistar Rats

    Article • Physiological Research, December 2021, Institute of Physiology of the Czech Academy of Sciences

    Dr Katarina Sebekova

  21. Creatinine-Based Formulae Poorly Match in the Classification of Hypofiltration or Hyperfiltration in a General Population of Adolescents: A Retrospective Analysis of a Cross-Sectional Study

    Article • Frontiers in Pediatrics, October 2021, Frontiers

    Dr Katarina Sebekova

  22. A considerable proportion of metabolic syndrome–free adults from Bratislava Region, Slovakia, display an increased cardiometabolic burden

    Article • Canadian Journal of Physiology and Pharmacology, September 2021, Canadian Science Publishing

    Dr Katarina Sebekova

  23. Bone mineral density and oxidative stress in adolescent girls with anorexia nervosa

    Article • European Journal of Pediatrics, July 2021, Springer Science + Business Media

    Dr Katarina Sebekova

  24. Circulating extracellular DNA is in association with continuous metabolic syndrome score in healthy adolescents

    Article • Physiological Genomics, July 2021, American Physiological Society

    Dr Katarina Sebekova

  25. Oxidative status in plasma, urine and saliva of girls with anorexia nervosa and healthy controls: a cross-sectional study

    Article • Journal of Eating Disorders, April 2021, Springer Science + Business Media

    Dr Katarina Sebekova

  26. Neurodevelopmental testing of mice in the neonatal period does not affect their locomotor activity, depressive- and anxiety-like behaviour in adolescence

    Article • Behavioural Brain Research, April 2021, Elsevier

    Dr Katarina Sebekova

  27. Dynamics of salivary markers of kidney functions in acute and chronic kidney diseases

    Article • Scientific Reports, December 2020, Springer Science + Business Media

    Dr Katarina Sebekova

  28. Asymptomatic Hyperuricemia Associates with Cardiometabolic Risk Indicators in Overweight/Obese but Not in Lean Adolescents

    Article • Diabetes Metabolic Syndrome and Obesity, October 2020, Taylor & Francis

    Dr Katarina Sebekova

  29. Sex Differences in Association of Elevated Blood Pressure with Variables Characterizing Cardiometabolic Risk in Young Subjects with or Without Metabolic Abnormalities

    Article • International Journal of Environmental Research and Public Health, May 2020, MDPI AG

    Dr Katarina Sebekova

  30. Elevated blood pressure-associated cardiometabolic risk factors and biomarkers in 16–23 years old students with or without metabolic abnormalities

    Article • Journal of Human Hypertension, February 2020, Springer Science + Business Media

    Dr Katarina Sebekova

  31. Estimation of the proportion of metabolic syndrome-free subjects on high cardiometabolic risk using two continuous cardiometabolic risk scores: a cross-sectional study in 16- to 20-year-old individuals

    Article • European Journal of Pediatrics, June 2019, Springer Science + Business Media

    Dr Katarina Sebekova

  32. Maternal Consumption of a Diet Rich in Maillard Reaction Products Accelerates Neurodevelopment in F1 and Sex-Dependently Affects Behavioral Phenotype in F2 Rat Offspring

    Article • Foods, May 2019, MDPI AG

    Dr Katarina Sebekova

  33. Metabolic and Renal Effects of Dietary Advanced Glycation end Products in Pregnant Rats – A Pilot Study

    Article • Physiological Research, March 2019, Institute of Physiology of the Czech Academy of Sciences

    Dr Katarina Sebekova

  34. Markers of Oxidative Stress and Antioxidant Status in the Plasma, Urine and Saliva of Healthy Mice

    Article • Physiological Research, December 2018, Institute of Physiology of the Czech Academy of Sciences

    Dr Katarina Sebekova

  35. Glycated proteins in nutrition: Friend or foe?

    Article • Experimental Gerontology, November 2018, Elsevier

    Dr Katarina Sebekova

  36. Gender-associated differences in the prevalence of central obesity using waist circumference and waist-to-height ratio, and that of general obesity, in Slovak adults

    Article • Central European Journal of Public Health, September 2018, National Institute of Public Health

    Dr Katarina Sebekova

  37. Salivary creatinine and urea are higher in an experimental model of acute but not chronic renal disease

    Article • PLOS One, July 2018, PLOS

    Dr Katarina Sebekova

  38. Plasma markers of oxidative status were associated with increasing continuous cardiometabolic risk scores in healthy students aged 16-20 years without central obesity

    Article • Acta Paediatrica, May 2018, Wiley

    Dr Katarina Sebekova

  39. Prevalence of overweight/obesity among 7-year-old children—WHO Childhood Obesity Surveillance Initiative in Slovakia, trends and differences between selected European countries

    Article • European Journal of Pediatrics, April 2018, Springer Science + Business Media

    Dr Katarina Sebekova

  40. Oxidative stress in the brain caused by acute kidney injury

    Article • Metabolic Brain Disease, March 2018, Springer Science + Business Media

    Dr Katarina Sebekova

  41. The effects of a maternal advanced glycation end product-rich diet on somatic features, reflex ontogeny and metabolic parameters of offspring mice

    Article • Food & Function, January 2018, Royal Society of Chemistry

    Dr Katarina Sebekova

  42. Continuous metabolic syndrome score (siMS) enables quantification of severity of cardiometabolic affliction in individuals not presenting with metabolic syndrome

    Article • Bratislava Medical Journal, January 2018, AEPress, s.r.o.

    Dr Katarina Sebekova

  43. Gender Differences in Cardiometabolic Risk Factors in Metabolically Healthy Normal Weight Adults with Central Obesity

    Article • Experimental and Clinical Endocrinology & Diabetes, November 2017, Thieme Publishing Group

    Dr Katarina Sebekova

  44. Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus

    Article • PLOS One, September 2017, PLOS

    Dr Katarina Sebekova

  45. Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia

    Article • Stem Cell Research & Therapy, July 2017, Springer Science + Business Media

    Dr Katarina Sebekova

  46. Association between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and activity of semicarbazide-sensitive amine oxidase

    Article • Croatian Medical Journal, April 2017, Croatian Medical Journal

    Dr Katarina Sebekova

  47. Variables associated with unplanned general adult ICU admission in hospitalised patients: protocol for a systematic review

    Article • Systematic Reviews, March 2017, Springer Science + Business Media

    Dr Katarina Sebekova

  48. Vitamin D status in apparently healthy medication-free Slovaks: Association to blood pressure, body mass index, self-reported smoking status and physical activity

    Article • Bratislava Medical Journal, January 2017, AEPress, s.r.o.

    Dr Katarina Sebekova

  49. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study

    Article • Glycoconjugate Journal, June 2016, Springer Science + Business Media

    Dr Katarina Sebekova

  50. Salivary markers of kidney function — Potentials and limitations

    Article • Clinica Chimica Acta, January 2016, Elsevier

    Dr Katarina Sebekova

  51. Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus

    Article • Biomedical Papers, November 2015, Palacky University Olomouc

    Dr Katarina Sebekova

  52. Vitamin D Levels Decline with Rising Number of Cardiometabolic Risk Factors in Healthy Adults: Association with Adipokines, Inflammation, Oxidative Stress and Advanced Glycation Markers

    Article • PLOS One, June 2015, PLOS

    Dr Katarina Sebekova

  53. Presence of Cardiometabolic Risk Factors Is Not Associated with Microalbuminuria in 14-to-20-Years Old Slovak Adolescents: A Cross-Sectional, Population Study

    Article • PLOS One, June 2015, PLOS

    Dr Katarina Sebekova

  54. Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST

    Article • Nanotoxicology, April 2015, Taylor & Francis

    Dr Katarina Sebekova

  55. Prenatal dietary load of Maillard reaction products combined with postnatal Coca-Cola drinking affects metabolic status of female Wistar rats

    Article • Croatian Medical Journal, April 2015, Croatian Medical Journal

    Dr Katarina Sebekova

  56. 25-Hydroxyvitamin D and Advanced Glycation Endproducts in Healthy and Hypertensive Subjects: Are There Interactions?

    Article • Journal of Renal Nutrition, March 2015, Elsevier

    Dr Katarina Sebekova

  57. Chronic renal insufficiency does not induce behavioral and cognitive alteration in rats

    Article • Physiology & Behavior, January 2015, Elsevier

    Dr Katarina Sebekova

  58. Extraskeletal Functions of Vitamin D

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Katarina Sebekova

  59. Interplay of Vitamin D, Erythropoiesis, and the Renin-Angiotensin System

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Katarina Sebekova

  60. Is Vitamin D Deficiency Related to Accumulation of Advanced Glycation End Products, Markers of Inflammation, and Oxidative Stress in Diabetic Subjects?

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Katarina Sebekova

  61. A pilot study of a genetic CJD risk factor (E200K) in the general Slovak population

    Article • European Journal of Epidemiology, July 2014, Springer Science + Business Media

    Dr Katarina Sebekova

  62. 26. Advanced glycation end products in infant formulas

    Article • June 2014, Brill

    Dr Katarina Sebekova

  63. Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? – In the search for minimizing of the adverse effects of PAMAM administration

    Article • International Journal of Pharmaceutics, April 2014, Elsevier

    Dr Katarina Sebekova

  64. Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2014, De Gruyter

    Dr Katarina Sebekova

  65. Skin autofluorescence reference values from newborns to adults

    Article • Diabetic Medicine, October 2013, Wiley

    Dr Katarina Sebekova

  66. Neuronal Activation in the Central Nervous System of Rats in the Initial Stage of Chronic Kidney Disease-Modulatory Effects of Losartan and Moxonidine

    Article • PLOS One, June 2013, PLOS

    Dr Katarina Sebekova

  67. Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats

    Article • Nanotoxicology, January 2013, Taylor & Francis

    Dr Katarina Sebekova

  68. Sex differences of oxidative stress markers in young healthy subjects are marker-specific in plasma but not in saliva

    Article • Annals of Human Biology, January 2013, Taylor & Francis

    Dr Katarina Sebekova

  69. Advanced Glycation End Products in Infant Formulas Do Not Contribute to Insulin Resistance Associated with Their Consumption

    Article • PLOS One, January 2013, PLOS

    Dr Katarina Sebekova

  70. Neuromuscular electrostimulation techniques: historical aspects and current possibilities in treatment of pain and muscle waisting

    Article • Clinical Nephrology, December 2012, Dustri-Verlgag Dr. Karl Feistle

    Dr Katarina Sebekova

  71. Influence Of Intensive Exercise On Renal Functions (Rf) And Advanced Glycation End-Products (Ages)

    Article • Kidney Research and Clinical Practice, June 2012, Elsevier

    Dr Katarina Sebekova

  72. The Effects of Anti-Inflammatory and Anti-Angiogenic DNA Vaccination on Diabetic Nephropathy in Rats

    Article • Human Gene Therapy, February 2012, Mary Ann Liebert Inc

    Dr Katarina Sebekova

  73. Behaviour and hormonal status in healthy rats on a diet rich in Maillard reaction products with or without solvent extractable aroma compounds

    Article • Physiology & Behavior, February 2012, Elsevier

    Dr Katarina Sebekova

  74. Advanced Oxidation Protein Products and Advanced Glycation End Products in Children and Adolescents With Chronic Renal Insufficiency

    Article • Journal of Renal Nutrition, January 2012, Elsevier

    Dr Katarina Sebekova

  75. The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats

    Article • Kidney International, December 2011, Elsevier

    Dr Katarina Sebekova

  76. Association of sVAP-1, sRAGE, and CML with lactation-induced insulin sensitivity in young non-diabetic healthy women

    Article • Clinica Chimica Acta, September 2011, Elsevier

    Dr Katarina Sebekova

  77. Advanced glycation end products in myocardial reperfusion injury

    Article • Heart and Vessels, May 2011, Springer Science + Business Media

    Dr Katarina Sebekova

  78. Metabolic syndrome is inversely related to soluble receptor for advanced glycation end products: a study in mother-infant pairs

    Article • Biopolymers and Cell, March 2011, Institute of Molecular Biology and Genetics (NAS Ukraine)

    Dr Katarina Sebekova

  79. Karl Peter’s fundamental contribution to the structural organization of the kidney

    Article • Journal of Nephrology, January 2011, Wichtig

    Dr Katarina Sebekova

  80. AT1 Receptor Antagonist Candesartan Attenuates Genomic Damage in Peripheral Blood Lymphocytes of Patients on Maintenance Hemodialysis Treatment

    Article • Kidney and Blood Pressure Research, January 2011, Karger Publishers

    Dr Katarina Sebekova

  81. Renal and metabolic effects of three months of decarbonated cola beverages in rats

    Article • Experimental Biology and Medicine, November 2010, SAGE Publications

    Dr Katarina Sebekova

  82. AGEs Fluorescence of Plasma, Urine and Skin Reflects Dietary Exposure to Maillard Products in Formula-fed Infants

    Article • September 2010, Royal Society of Chemistry

    Dr Katarina Sebekova

  83. Mechanisms of Acute Uremic Encephalopathy: Early Activation of Fos and Fra-2 Gene Products in Different Nuclei/Areas of the Rat Brain

    Article • Journal of Renal Nutrition, September 2010, Elsevier

    Dr Katarina Sebekova

  84. Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers

    Article • Clinica Chimica Acta, August 2010, Elsevier

    Dr Katarina Sebekova

  85. Oxidative stress, advanced glycation end products and residual renal function in the rat model of unilateral ureteral obstruction: effects of phlogenzym and losartan

    Article • Biopolymers and Cell, March 2010, Institute of Molecular Biology and Genetics (NAS Ukraine)

    Dr Katarina Sebekova

  86. Advanced Glycation End Products and Acute Myocardial Infarction

    Article • Medical Principles and Practice, January 2010, Karger Publishers

    Dr Katarina Sebekova

  87. Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amosite

    Article • Journal of Cellular and Molecular Medicine, November 2009, Wiley

    Dr Katarina Sebekova

  88. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats

    Article • Metabolism, November 2009, Elsevier

    Dr Katarina Sebekova

  89. Testing strategies for the safety of nanoparticles used in medical applications

    Article • Nanomedicine, August 2009, Future Medicine

    Dr Katarina Sebekova

  90. Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST – EC FP7 project

    Article • Journal of Physics Conference Series, May 2009, Institute of Physics Publishing

    Dr Katarina Sebekova

  91. Neuronal activation in the CNS during different forms of acute renal failure in rats

    Article • Neuroscience, March 2009, Elsevier

    Dr Katarina Sebekova

  92. Plasma advanced glycation end products are decreased in obese children compared with lean controls

    Article • International Journal of Pediatric Obesity, January 2009, Taylor & Francis

    Dr Katarina Sebekova

  93. Functional and Partial Morphological Regression of Established Renal Injury in the Obese Zucker Rat by Blockade of the Renin-Angiotensin System

    Article • American Journal of Nephrology, January 2009, Karger Publishers

    Dr Katarina Sebekova

  94. Entwicklung der Peritonealdialyse

    Article • Nieren- und Hochdruckkrankheiten, January 2009, Dustri-Verlgag Dr. Karl Feistle

    Dr Katarina Sebekova

  95. Einfluss proteolytischer Enzyme auf Advanced Glycation Endproducts (AGEs) – Mögliche klinische Implikationen?

    Article • DMW - Deutsche Medizinische Wochenschrift, December 2008, Thieme Publishing Group

    Dr Katarina Sebekova

  96. PAMAM G4 dendrimers lower high glucose but do not improve reduced survival in diabetic rats

    Article • International Journal of Pharmaceutics, November 2008, Elsevier

    Dr Katarina Sebekova

  97. Les produits de Maillard issus de la cuisson ont-ils des effets biologiques ?

    Article • Sciences des Aliments, June 2008, Lavoisier

    Dr Katarina Sebekova

  98. Plasma Concentration and Urinary Excretion of Nɛ-(Carboxymethyl)lysine in Breast Milk- and Formula-fed Infants

    Article • Annals of the New York Academy of Sciences, April 2008, Wiley

    Dr Katarina Sebekova

  99. Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function

    Article • Kidney International, November 2007, Elsevier

    Dr Katarina Sebekova

  100. The Selective TP Receptor Antagonist, S18886 (Terutroban), Attenuates Renal Damage in the Double Transgenic Rat Model of Hypertension

    Article • American Journal of Nephrology, September 2007, Karger Publishers

    Dr Katarina Sebekova

  101. Dietary advanced glycation endproducts (AGEs) and their health effects - PRO

    Article • Molecular Nutrition & Food Research, September 2007, Wiley

    Dr Katarina Sebekova

  102. Treatment targets in renal fibrosis

    Article • Nephrology Dialysis Transplantation, August 2007, Oxford University Press (OUP)

    Dr Katarina Sebekova

  103. Renal Effects of S18886 (Terutroban), a TP Receptor Antagonist, in an Experimental Model of Type 2 Diabetes

    Article • Diabetes, January 2007, American Diabetes Association

    Dr Katarina Sebekova

  104. Reply

    Article • Kidney and Blood Pressure Research, January 2007, Karger Publishers

    Dr Katarina Sebekova

  105. Genomic Damage and Malignancy in End-Stage Renal Failure: Do Advanced Glycation End Products Contribute?

    Article • Kidney and Blood Pressure Research, December 2006, Karger Publishers

    Dr Katarina Sebekova

  106. Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians

    Article • Molecular Nutrition & Food Research, September 2006, Wiley

    Dr Katarina Sebekova

  107. Renal Disease in Obesity: The Need for Greater Attention

    Article • Journal of Renal Nutrition, July 2006, Elsevier

    Dr Katarina Sebekova

  108. Relation between Different Treatment Modalities and Genomic Damage of End-Stage Renal Failure Patients

    Article • Kidney and Blood Pressure Research, January 2006, Karger Publishers

    Dr Katarina Sebekova

  109. Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats

    Article • Physiological Research, January 2006, Institute of Physiology of the Czech Academy of Sciences

    Dr Katarina Sebekova

  110. Tissue viral DNA is associated with chronic allograft nephropathy

    Article • Pediatric Transplantation, October 2005, Wiley

    Dr Katarina Sebekova, Professor Guido Filler

  111. Genetic variability in the RAGE gene: Possible implications for nutrigenetics, nutrigenomics, and understanding the susceptibility to diabetic complications

    Article • Molecular Nutrition & Food Research, July 2005, Wiley

    Dr Katarina Sebekova

  112. Renal Effects of Oral Maillard Reaction Product Load in the Form of Bread Crusts in Healthy and Subtotally Nephrectomized Rats

    Article • Annals of the New York Academy of Sciences, June 2005, Wiley

    Dr Katarina Sebekova

  113. Increased Protein Glycation in Cirrhosis and Therapeutic Strategies to Prevent It

    Article • Annals of the New York Academy of Sciences, June 2005, Wiley

    Dr Katarina Sebekova

  114. Dietary Bread Crust Advanced Glycation End Products Bind to the Receptor for AGEs in HEK-293 Kidney Cells but Are Rapidly Excreted after Oral Administration to Healthy and Subtotally Nephrectomized Rats

    Article • Annals of the New York Academy of Sciences, June 2005, Wiley

    Dr Katarina Sebekova

  115. Reduced Circulating AGE Levels and Lower Genomic Damage in Patients Undergoing Daily versus Standard Hemodialysis

    Article • Annals of the New York Academy of Sciences, June 2005, Wiley

    Dr Katarina Sebekova

  116. Advanced Glycation End Product-Induced DNA Damage: Involvement of Angiotensin II

    Article • Annals of the New York Academy of Sciences, June 2005, Wiley

    Dr Katarina Sebekova

  117. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis

    Article • Nephrology Dialysis Transplantation, May 2005, Oxford University Press (OUP)

    Dr Katarina Sebekova

  118. Genomic damage in chronic renal failure—potential therapeutic interventions

    Article • Journal of Renal Nutrition, January 2005, Elsevier

    Dr Katarina Sebekova

  119. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis

    Article • Journal of Hepatology, December 2004, Elsevier

    Dr Katarina Sebekova

  120. Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation

    Article • Heart, November 2004, BMJ

    Dr Katarina Sebekova

  121. Genomic damage in end-stage renal failure: Potential involvement of advanced glycation end products and carbonyl stress

    Article • Seminars in Nephrology, September 2004, Elsevier

    Dr Katarina Sebekova

  122. Die Bedeutung von Übergewicht und Adipositas für Entstehung und Verlauf renaler Erkrankungen

    Article • DMW - Deutsche Medizinische Wochenschrift, March 2004, Thieme Publishing Group

    Dr Katarina Sebekova

  123. Serum Growth Factors in Hemodialyzed Patients

    Article • Artificial Organs, March 2004, Wiley

    Dr Katarina Sebekova

  124. Functional Hyperhomocysteinemia in Healthy Vegetarians: No Association with Advanced Glycation End Products, Markers of Protein Oxidation, or Lipid Peroxidation after Correction with Vitamin B12

    Article • Clinical Chemistry, June 2003, Oxford University Press (OUP)

    Dr Katarina Sebekova

  125. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products

    Article • Journal of Human Hypertension, April 2003, Springer Science + Business Media

    Dr Katarina Sebekova

  126. Effects of a diet rich in advanced glycation end products in the rat remnant kidney model

    Article • American Journal of Kidney Diseases, March 2003, Elsevier

    Dr Katarina Sebekova

  127. Genotoxicity of advanced glycation end products in mammalian cells

    Article • Cancer Letters, February 2003, Elsevier

    Dr Katarina Sebekova

  128. Effects of dietary Nε-carboxymethyllysine on expression of the biotransformation enzyme, glutathione-S-transferase, in the rat

    Article • International Congress Series, November 2002, Elsevier

    Dr Katarina Sebekova

  129. Advanced glykation end products in patients with liver cirrhosis before and after liver transplantation

    Article • Journal of Hepatology, April 2002, Elsevier

    Dr Katarina Sebekova

  130. Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis – amelioration by liver transplantation

    Article • Journal of Hepatology, January 2002, Elsevier

    Dr Katarina Sebekova

  131. Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet

    Article • Zeitschrift für Ernährungswissenschaft, December 2001, Springer Science + Business Media

    Dr Katarina Sebekova

  132. Plasma levels of advanced glycation end products in children with renal disease

    Article • Pediatric Nephrology, December 2001, Springer Science + Business Media

    Dr Katarina Sebekova

  133. Advanced glycation end products and the progressive course of renal disease

    Article • American Journal of Kidney Diseases, October 2001, Elsevier

    Dr Katarina Sebekova

  134. Advanced glycation end products (AGEs)‐induced expression of TGF‐β1 is suppressed by a protease in the tubule cell line LLC‐PK1

    Article • Nephrology Dialysis Transplantation, August 2001, Oxford University Press (OUP)

    Dr Katarina Sebekova

  135. DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan

    Article • Kidney International, February 2001, Elsevier

    Dr Katarina Sebekova

  136. Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin

    Article • Kidney International, February 2001, Elsevier

    Dr Katarina Sebekova

  137. Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin

    Article • Kidney International, February 2001, Elsevier

    Dr Katarina Sebekova

  138. DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan

    Article • Kidney International, February 2001, Elsevier

    Dr Katarina Sebekova

  139. Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure

    Article • Kidney International, February 2001, Elsevier

    Dr Katarina Sebekova

  140. Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure

    Article • Kidney International, February 2001, Elsevier

    Dr Katarina Sebekova

  141. Advanced Glycation End Products in End-Stage Renal Disease and Their Removal

    Article • January 2001, Karger Publishers

    Dr Katarina Sebekova

  142. Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension

    Article • Journal of Human Hypertension, January 2001, Nature

    Dr Katarina Sebekova

  143. Evidence for Accumulation of Advanced Glycation End Products in Acute Renal Failure

    Article • January 2000, Karger Publishers

    Dr Katarina Sebekova

  144. Enalapril Inhibits Growth and Proliferation of Various Tissues in Rat Normotensive Four–Sixths Kidney Ablation Nephropathy

    Article • Kidney and Blood Pressure Research, January 2000, Karger Publishers

    Dr Katarina Sebekova

  145. The effect of oral protease administration in the rat remnant kidney model

    Article • Research in Experimental Medicine, May 1999, Springer Science + Business Media

    Dr Katarina Sebekova

  146. Suppressed Activities of Cathepsins and Metalloproteinases in the Chronic Model of Puromycin Aminonucleoside Nephrosis

    Article • Kidney and Blood Pressure Research, January 1999, Karger Publishers

    Dr Katarina Sebekova

  147. Advanced Glycation End-Product Levels in Subtotally Nephrectomized Rats: Beneficial Effects of Angiotensin II Receptor 1 Antagonist Losartan

    Article • Mineral and Electrolyte Metabolism, January 1999, Karger Publishers

    Dr Katarina Sebekova

  148. Effective long-term inhibition of thromboxane production but not of serotonin release in patients with coronary heart disease by 30 mg/d acetylsalicylic acid dosage

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, July 1998, Elsevier

    Dr Katarina Sebekova

  149. Mesangial cell hypertrophy induced by NH4Cl: Role of depressed activities of cathepsins due to elevated lysosomal pH

    Article • Kidney International, June 1998, Elsevier

    Dr Katarina Sebekova

  150. High-Glucose Media Enhance the Responsiveness of Tubular Cells to Growth Promoters: Effect on Lysosomal Cathepsins and Protein Degradation

    Article • Mineral and Electrolyte Metabolism, January 1998, Karger Publishers

    Dr Katarina Sebekova

  151. Nutritional Management of the Uremic Patient

    Article • January 1998, Springer Science + Business Media

    Dr Katarina Sebekova

  152. Effect of Chronic Therapy with Proteolytic Enzymes on Hypertension-Induced Renal Injury in the Rat Model of Goldblatt Hypertension

    Article • American Journal of Nephrology, January 1998, Karger Publishers

    Dr Katarina Sebekova

  153. Inhibition of glucose uptake by 5-hydroxyindoleacetic acid in the isolated rat soleus muscle

    Article • International Urology and Nephrology, January 1996, Springer Science + Business Media

    Dr Katarina Sebekova

  154. Plasma Levels of 5-Hydroxyindole-Acetic Acid in Chronic Renal Insufficiency and Their Effect on Platelet Aggregation

    Article • January 1991, Karger Publishers

    Dr Katarina Sebekova

  155. Serotonin and Platelet Activation During Treatment with Isradipine

    Article • Journal of Cardiovascular Pharmacology, January 1991, Wolters Kluwer Health

    Dr Katarina Sebekova

  156. Serotonin and Platelet Activation During Treatment with Isradipine

    Article • Journal of Cardiovascular Pharmacology, January 1991, Wolters Kluwer Health

    Dr Katarina Sebekova

  157. Serotonin Metabolism in Patients with Decreased Renal Function

    Article • January 1989, Karger Publishers

    Dr Katarina Sebekova

  158. Perturbation of baseline in HPLC analysis as the consequence of sample injection

    Article • Journal of High Resolution Chromatography, August 1988, Wiley

    Dr Katarina Sebekova

  159. Serotonin Metabolism and Platelet Aggregation Under Antihypertensive Treatment with Nitrendipine

    Article • Journal of Cardiovascular Pharmacology, January 1988, Wolters Kluwer Health

    Dr Katarina Sebekova

  160. Evaluation of various bonded-phase materials for the off-line clean-up procedure of urinary 5-hydroxyindolacetic acid prior to its determination by HPLC

    Article • Chromatographia, December 1986, Springer Science + Business Media

    Dr Katarina Sebekova

  161. Dependence of the separation of some biological substances on the carbon content of C18 chemically bonded phases

    Article • Journal of Chromatography A, January 1986, Elsevier

    Dr Katarina Sebekova